Deakin University
Browse

Cancer stem cell targeted therapy: progress amid controversies

Download (3.46 MB)
Version 3 2024-06-17, 16:05
Version 2 2024-06-05, 03:57
Version 1 2016-01-06, 09:18
journal contribution
posted on 2024-06-17, 16:05 authored by T Wang, Sarah ShigdarSarah Shigdar, MP Gantier,, Y Hou,, L Wang,, Y Li,, HA Shamaileh,, W Yin, SF Zhou,, X Zhao,, Wei DuanWei Duan
Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cells may undergo reversible phenotypic changes; and the cancer stem cells phenotype can vary substantially between patients. Here the current status and progresses of cancer stem cells theory is illustrated and via providing a panoramic view of cancer therapy, we addressed the recent controversies regarding the feasibility of cancer stem cells targeted anti-cancer therapy.

History

Journal

Oncotarget

Volume

6

Pagination

44191-44206

Location

Albany, N.Y.

Open access

  • Yes

eISSN

1949-2553

Language

eng

Publication classification

C Journal article, C1 Refereed article in a scholarly journal

Copyright notice

2015, The Authors

Issue

42

Publisher

Impact Journals